Terms: = Leukemia AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
1153 results:
1. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.
Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
[TBL] [Abstract] [Full Text] [Related]
2. Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis.
Qiu Y; Bai L; Zhao H; Mei X
BMC Cancer; 2024 Apr; 24(1):520. PubMed ID: 38658865
[TBL] [Abstract] [Full Text] [Related]
3. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/erk and STAT3/c-Myc Pathways.
Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
[TBL] [Abstract] [Full Text] [Related]
4. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells.
Camoglio C; Balla J; Fadda P; Dedoni S
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
[TBL] [Abstract] [Full Text] [Related]
5. Assessment of the FRET-based Teen sensor to monitor erk activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor.
Fasano G; Petrini S; Bonavolontà V; Paradisi G; Pedalino C; Tartaglia M; Lauri A
Mol Med; 2024 Apr; 30(1):47. PubMed ID: 38594640
[TBL] [Abstract] [Full Text] [Related]
6. Dachshund Homolog 1: Unveiling Its Potential Role in Megakaryopoiesis and
Lin GL; Chang HH; Lin WT; Liou YS; Lai YL; Hsieh MH; Chen PK; Liao CY; Tsai CC; Wang TF; Chu SC; Kau JH; Huang HH; Hsu HL; Sun DS
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542074
[TBL] [Abstract] [Full Text] [Related]
7. LSP1 promotes the progression of acute myelogenous leukemia by regulating KSR/erk signaling pathway and cell migration.
Li T; Gui X; Li B; Hu X; Wang Y
Hematology; 2024 Dec; 29(1):2330285. PubMed ID: 38511641
[TBL] [Abstract] [Full Text] [Related]
8. Azacitidine-Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human leukemia Cells.
Lai KM; Tseng RH; Shih YH; Huang YC
Anticancer Res; 2024 Mar; 44(3):1033-1044. PubMed ID: 38423637
[TBL] [Abstract] [Full Text] [Related]
9. Licochalcone A induces mitochondria-dependent apoptosis and interacts with venetoclax in acute myeloid leukemia.
Li Y; Zhao M; Lin Y; Jiang X; Jin L; Ye P; Lu Y; Pei R; Jiang L
Eur J Pharmacol; 2024 Apr; 968():176418. PubMed ID: 38350590
[TBL] [Abstract] [Full Text] [Related]
10. IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation.
Yang J; Chen J; Chang J; Sun X; Wei Q; Cai X; Cao P
Cell Commun Signal; 2024 Feb; 22(1):116. PubMed ID: 38347540
[TBL] [Abstract] [Full Text] [Related]
11. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
[TBL] [Abstract] [Full Text] [Related]
12. Induction of apoptosis and autophagy by dichloromethane extract from Patrinia scabiosaefolia Fisch on acute myeloid leukemia cells.
Li K; Mi L; Bai X; Lu Y; Zhang Y; Li J; Pu Y
Environ Toxicol; 2024 Apr; 39(4):2123-2137. PubMed ID: 38108539
[TBL] [Abstract] [Full Text] [Related]
13. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression.
Chiou JT; Chang LS
Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391
[TBL] [Abstract] [Full Text] [Related]
14. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia.
Gaur T; Ali A; Sharma D; Gupta SK; Gota V; Bagal B; Platzbeckar U; Mishra R; Dutt A; Khattry N; Mills K; Hassan MI; Sandur S; Hasan SK
Cell Signal; 2024 Feb; 114():111004. PubMed ID: 38048856
[TBL] [Abstract] [Full Text] [Related]
15. The Flt3-inhibitor quizartinib augments apoptosis and promotes maladaptive remodeling after myocardial infarction in mice.
Monogiou Belik D; Bernasconi R; Xu L; Della Verde G; Lorenz V; Grüterich V; Balzarolo M; Mochizuki M; Pfister O; Kuster GM
Apoptosis; 2024 Apr; 29(3-4):357-371. PubMed ID: 37945814
[TBL] [Abstract] [Full Text] [Related]
16. MEK/erk and PI3K/AKT pathway inhibitors affect the transformation of myelodysplastic syndrome into acute myeloid leukemia via H3K27me3 methylases and de‑methylases.
Zheng Z; Chen X; Zhang Y; Ren F; Ma Y
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37921060
[TBL] [Abstract] [Full Text] [Related]
17. Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid leukemia by Inhibiting MEK/erk and p38-MAPK Signaling Pathways.
Li G; Yao J; Lu Z; Yu L; Chen Q; Ding L; Fang Z; Li Y; Xu B
Drugs R D; 2023 Dec; 23(4):439-451. PubMed ID: 37847357
[TBL] [Abstract] [Full Text] [Related]
18. KZ02 enhances the radiosensitivity of BRAF-mutated CRC in vitro and in vivo.
Guo Y; Li X; Yuan R; Ren J; Huang Y; Yu Y; Tian H
Eur J Pharmacol; 2023 Nov; 959():176060. PubMed ID: 37775019
[TBL] [Abstract] [Full Text] [Related]
19. DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/erk activity in gastric cancer cells.
Chen Z; Zhang L; Yang Y; Liu H; Kang X; Nie Y; Fan D
Epigenetics; 2023 Dec; 18(1):2254976. PubMed ID: 37691391
[TBL] [Abstract] [Full Text] [Related]
20. Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression.
Du A; Yang Q; Sun X; Zhao Q
Int Immunopharmacol; 2023 Nov; 124(Pt A):110868. PubMed ID: 37657244
[TBL] [Abstract] [Full Text] [Related]
[Next]
